Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human LILRA5/CD85f Alexa Fluor 700-conjugated Antibody, R&D Systems™
Mouse Monoclonal Antibody
Supplier: R&D Systems FAB6754N100UG
This item is not returnable.
View return policy
Description
ILT11/LILRA5 Monoclonal specifically detects ILT11/LILRA5 in Human samples. It is validated for Flow Cytometry.Specifications
ILT11/LILRA5 | |
Monoclonal | |
Alexa Fluor 700 | |
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide. with Sodium Azide | |
CD85, CD85 antigen-like family member F, CD85F, CD85f antigen, ILT11, ILT-11, ILT11CD85f, Immunoglobulin-like transcript 11, leukocyte Ig-like receptor 9, Leukocyte immunoglobulin-like receptor 9, leukocyte immunoglobulin-like receptor subfamily A member 5, leukocyte immunoglobulin-like receptor subfamily A member 5 soluble, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LILRB7, LIR9, LIR-9, LIR9immunoglobulin-like transcript 11 protein, member 7 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
Primary | |
Detects human ILT11/LILRA5 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant mouse ILT11/LILRA5, recombinant rat (rr) ILT11/LILRA5, rrLILRC2, recombinant human (rh) ILT4/CD85d, rhILT5/CD85a, or rhILT3/CD85k is observed. | |
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8°C as supplied. | |
IgG2a |
Flow Cytometry | |
711828 | |
Flow Cytometry 0.25-1 μg/106 cells | |
A6NI73 | |
LILRA5 | |
Chinese hamster ovary cell line CHO-derived recombinant human ILT11/LILRA5, Gly42-Arg268, Accession # A6NI73 | |
100 μg | |
353514 | |
Human | |
Supernatant |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction